BioCentury
ARTICLE | Clinical News

Joulferon albinterferon alfa-2b regulatory update

December 21, 2009 8:00 AM UTC

Novartis submitted an MAA to the EMEA for Joulferon albinterferon alfa-2b to treat chronic HCV. The fusion protein of interferon alpha and albumin is partnered with Human Genome Sciences Inc., which s...